Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Duffy

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Digestive Diseases (Basel, Switzerland)|May 4, 2017
Treating Hepatobiliary Cancer: The Immunologic ApproachA G Duffy, T F Greten
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2013
Immunological off-target effects of standard treatments in gastrointestinal cancersA G Duffy, T F Greten
Expert Opinion on Emerging Drugs|December 23, 2021
Recent advances in immune-based approaches for the treatment of esophagogastric cancerC S Weadick, A G Duffy, R J Kelly
Irish Journal of Medical Science|November 1, 2006
Taxane-resistant lymphoepithelial-like carcinoma: excellent response to VIP chemotherapyA G Duffy, G Wyse, A M Horgan, et al.
Case Reports in Women'S Health|February 24, 2022
Investigating a clinically actionable <i>BRAF</i> mutation for monitoring low-grade serous ovarian cancer: A case reportR Silva, B Moran, S Das, et al.
United European Gastroenterology Journal|November 5, 2015
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenibA G Duffy, S V Ulahannan, L Cao, et al.
International Journal of Cancer|May 20, 2016
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Digestive Diseases (Basel, Switzerland)|May 4, 2017
Treating Hepatobiliary Cancer: The Immunologic ApproachA G Duffy, T F Greten
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2013
Immunological off-target effects of standard treatments in gastrointestinal cancersA G Duffy, T F Greten
Expert Opinion on Emerging Drugs|December 23, 2021
Recent advances in immune-based approaches for the treatment of esophagogastric cancerC S Weadick, A G Duffy, R J Kelly
Irish Journal of Medical Science|November 1, 2006
Taxane-resistant lymphoepithelial-like carcinoma: excellent response to VIP chemotherapyA G Duffy, G Wyse, A M Horgan, et al.
Case Reports in Women'S Health|February 24, 2022
Investigating a clinically actionable <i>BRAF</i> mutation for monitoring low-grade serous ovarian cancer: A case reportR Silva, B Moran, S Das, et al.
United European Gastroenterology Journal|November 5, 2015
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenibA G Duffy, S V Ulahannan, L Cao, et al.
International Journal of Cancer|May 20, 2016
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.
Pageof 1